Summary
The effects of serotonergic and antiserotonergic drugs on the hind limb flexor reflex (measured as a contraction of musculus tibialis anterior or as a flexion of the paw) in the spinal rat was studied. All serotonergic drugs used (L-5-hydroxytryptophan, L-tryptophan, LSD, fenfluramine, p-chloro-amphetamine) stimulate the flexor reflex. Serotonin receptor blockers (cyproheptadine, WA-335, methergoline), which given alone are inactive, inhibit the stimulation induced by serotonergic drugs but do not influence that one caused by noradrenergic agents (amphetamine, clonidine). Both types of stimulation (serotonergic and noradrenergic) are antagonized by noradrenaline receptor blockers (phenoxybenzamine, clozapine). The anti-serotonergic action of serotonin antagonists used was confirmed on the basis of the antagonism to the head twitches induced by L-5-hydroxytryptophan.
The flexor reflex in the spinal rat may be a good model to evaluate the effect on the central (spinal cord) serotonin receptor and to differantiate this effect from that on the noradrenaline system.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aghajanian, G. K., Freedman, D. X.: Biochemical and morphological aspects of LSD pharmacology. Psychopharmacology: A Review of Progress, edited byD. H. Efron. Washington D.C.: U.S. Govt. Printing Office, pp. 1185–1193 (1968).
Aghajanian, G. K., Haigler, H. J.: Mode of action of LSD on serotonergic neurons. Adv. Biochem. Psychopharmacol. Raven Press. New York10, 167–177 (1974).
Andén, N.-E.: Effects of amphetamine and some other drugs on central catecholamine mechanisms. Symposium on amphetamines and releated compounds (Costa, E., Garattini, S., eds.), pp. 447–462. North-Holland Publ. Co. 1970.
Andén, N.-E., Corrodi, H., Fuxe, K., Hökfelt, T.: Increased impulse flow in bulbospinal noradrenaline neurons produced by catecholamine receptor blocking agents. Europ. J. Pharmacol.2, 59–64 (1967).
Andén, N.-E., Corrodi, H., Fuxe, K., Hökfelt, T.: Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide. Br. J. Pharmac.34, 1–7 (1968).
Andén, N.-E., Engel, J., Rubenson, A.: Central decarboxylation and uptake of L-dopa. N.-S. Arch. Pharmacol.273, 11–26 (1972).
Andén, N.-E., Jukes, M. G. M., Lundberg, A.: Spinal reflexes and monoamine liberation. Nature202, 1222–1223 (1964).
Anderson, E. G.: Bulbospinal serotonin-containing neurons and motor control. Fed. Proc.31, 107–112 (1972).
Anderson, E. G., Shibuya, T.: The effects of 5-hydroxytryptamine and L-tryptophan on spinal synaptic activity. J. Pharmac. Exp. Ther.153, 352–360 (1966).
Banna, N. R., Anderson, E. G.: The effects of 5-hydroxytryptamine antagonists on spinal neuronal activity. J. Pharmacol. Exp. Ther.162, 319–325 (1968).
Barasi, S., Roberts, M. H. T.: The modification on lumbar motoneurone excitability by stimulation of a putative 5-hydroxytryptamine pathway. Br. J. Pharmac.52, 339–348 (1974).
Bartholini, G., Pletscher, A.: Two types of 5-hydroxytryptamine release from isolated blood platelets. Experientia20, 376–378 (1964).
Beretta, C., Glässer, A. H., Nobili, M. B., Silverstri, R.: Antagonism of 5-hydroxytryptamine-induced bromchospasm in guinea-pigs by 8-βcarbobenzyloxyaminomethyl-l-dimethyl-10-α-ergoline. J. Pharm. Pharmacol.17, 423–428 (1965).
Bloom, F. E., Hoffer, B. J., Nelson, C., Sheu, Y., Siggins, G. R.: The physiology and pharmacology of serotonin mediated synapses. In: Serotonin and Behavior (Barchas, J., Usdin, E., eds.), pp. 249–261. New York: Academic Press. 1973.
Bloom, F. E., Hoffer, B. J., Siggins, G. R., Barker, J. L., Nicoll, R. A.: Effects of serotonin on central neurons. Microiontophoretic administration. Fed. Proc.31, 97–106 (1972).
Boakes, R. J., Bradley, P. B., Briggs, I., Dray, A.: Antagonism of 5-hydroxytryptamine by LSD-25 in the central nervous system: A possible neuronal basis for the actions of LSD-25. Brit. J. Pharmacol.40, 202 to 218 (1970).
Carlsson, A.: Structural specificity for inhibition of (C14)-5-hydroxytryptamine uptake by cerebral slices. J. Pharm. Pharmacol.22, 729 to 732 (1970).
Carlsson, A., Falck, K., Fuxe, K., Hillarp, N. A.: Cellular localization of monoamines in the spinal cord. Acta Physiol. Scand.60, 112–119 (1964).
Corne, S. J., Pickering, R. W., Warner, B. T.: Method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine. Br. J. Pharmac. Chemother.20, 106–120 (1963).
Costa, E.: Effects of halucinogenic and tranquilizing drugs on serotonin evoked uterine contractions. Proc. Exptl. Biol. Med.91, 39–41 (1956).
Costa, E., Groppetti, A., Revuelta, A.: Action on fenfluramine on monoamine stores of rat tissue. Br. J. Pharmacol.41, 57–64 (1971).
Dahlström, A., Fuxe, K.: Evidence for the existence of monoamine neurones in the central nervous system. II. Experimentally induced changed in the intraneuronal amine levels of bulbo-spinal neurone systems. Acta Physiol. Scand.64, suppl.247 (1965).
Duhault, J., Verdavainne, C.: Modification of the level of cerebral serotonin in the rat by fenfluramine. Arch. Int. Pharmacodyn. Thér.170, 276 to 286 (1967).
Engelhardt, G.: Zur Pharmakologie des 9, 10-Dihydro-10-(1-methyl-4-piperidyliden)-9-anthrol (WA-335), eines Histaminund Serotonin-antagonisten. Arzneim.-Forsch. (Drug Res.)25, 1723–1737 (1975).
Ferrini, R., Glässer, A.: Antagonism of central effects of tryptamine and 5-hydroxytryptophan by 1,6-dimethyl-8-β-carbobenzyloxyamino-methyl-10-α-ergoline. Psychopharmacol.8, 271–276 (1965).
Frey, M. H., Magnussen, M. P.: Different central mediation of the stimulant effects of amphetamine and its p-chloroanalogue. Biochem. Pharmacol.17, 1229–1307 (1968).
Fuller, R. W., Hines, C. W., Mills, J.: Lowering of brain serotonin level by chloroamphetamines. Biochem. Pharmacol.14, 483–488 (1965).
Haigler, H. J., Aghajanian, G. K.: Peripheral serotonin antagonists: Failure to antagonize serotonin in brain areas receiving a prominent serotonergic input. Neural Transm.35, 257–273 (1974).
Kähling, J., Ziegler, H., Balhause, H.: Zentrale Wirkungen von WA-335-BS, einer Substanz mit peripherer Antiserotoninund Antihistamin-Wirkung. Arzneim.-Forsch. (Drug Res.)25, 1737–1744 (1975).
Little, K. D., Di Stefano, V., Leary, D. E.: LSD and serotonin effects on spinal reflexes in the cat. J. Pharmac. Exp. Ther.119, 161 (1957).
Maj, J., Baran, L., Sowińska, H., Gancarczyk, L.: Central action of WA-335. Arch. Immunol. Ther. Exp.1976, 24, in press.
Maj, J., Sowińska, H., Baran, L., Palider, W.: The central action of clozapine. Pol. J. Pharmacol. Pharm.26, 425–435 (1974).
Marley, E., Vane, J. R.: Tryptamine and spinal cord reflexes in cats. Br. J. Pharmac. Chemother.31, 447–465 (1967).
Martin, W. R., Eades, C. G.: The action of tryptamine on the dog spinal cord and its relationship to the agonistic actions of LSD-like psychotogenes. Psychopharmacol. (Berl.)17, 242–257 (1970).
Miller, K. W., Sanders-Bush, E., Dingell, J. V.: p-Chloroamphetamine-species differences in the rate of disappearance and the lowering of cerebral serotonin. Biochem. Pharmacol.20, 500–503 (1971).
Opitz, K.: Anorexigene Phenylalkylamine und Serotoninstoffwechsel. N.-S. Arch. Pharmakol. exp. Path.259, 56–65 (1967).
Palider, W., Przewlocka, B.: The influence of LSD on the hind limb flexor reflex in the spinal rat. Symposium “Serotonin Brain-Drugs”, October 15–16, 1974, Kazimierz Dolny. Pol. J. Pharmacol. Pharm.27, suppl. 173–179 (1975).
Pletscher, A., Bartholini, G., Bmderer, H., Burkard, W. P., Gey W. F.: Chlorinated arylalkylamines affecting the cerebral metabolism of 5-hydroxytryptamine. J. Pharmacol. Exp. Ther.145, 344–350 (1964).
Riezen, H. van: Different central effects of 5-HT antagonists mianserine and cyproheptadine. Arch. Int. Pharmacodyn. Thér.198, 256–269 (1972).
Roberts, M. H. T., Straughan, D. W.: The excitation and depression of cortical neurons by 5-hydroxytryptamine. J. Physiol.193, 269–294 (1969).
Shaw, E., Woolley, D. W.: Some serotonin-like activities of lysergid acid diethylamide. Science124, 121–122 (1956).
Slater, I. H., Davis, K. H., Leary, D. E., Boyd, E. S.: The action of serotonin and lysergic acid diethylamide on spinal reflexes. J. Pharmacol. Exp. Ther.113, 48–49 (1955).
Southgate, P. J., Mayer, S. R., Boxall, E., Wilson, A. B.: Some 5-hydroxytryptamine-like actions of fenfluramine: a comparison with (+)-amphetamine and diethylpropion. J. Pharm. Pharmac.23, 600–605 (1971).
Stille, G., Lauener, H., Eichenberger, E.: The pharmacology of 8-chloro-11-/4-methyl-l-piperazinyl/-5H-dibenzo/b, e/1, 4/diazepine/(clozapine). Il Farmaco, Ed. Pr.26, 603–625 (1971).
Stone, S. A., Wenger, H. C., Ludden, C. T., Stavorski, J. M., Ross, C. A.: Antiserotonin-antihistaminic properties of cyproheptadine. J. Pharmacol. Exp. Ther.131, 73–84 (1961).
Tagliamonte, A., Tagliamonte, P., Perez-Cruet, J., Stern, S., Gessa, G. L.: Effect of psychotropic drugs on tryptophan concentration in the rat brain. J. Pharmacol. Exp. Ther.177, 475–480 (1971).
Weidman, H., Cerletti, A.: Die Wirkung von D-Lysergsaure-diathylamidund 5-Hydroxytryptamin (Serotonin) auf spinale Reflexe der Katze. Helv. physiol. pharmacol. Acta15, 376–383 (1957).
Welsh, J. H.: Serotonin as a possible neurohumoral agents: Evidence obtained in lower animals. Ann. N.Y. Acad. Sci.66, 618–630 (1957).
Wrong, D. T., Horng, J. S., Fuller, R. W.: Kinetics of serotonin accumulation into synaptosomes of rat brain: Effects of amphetamine and chloroamphetamines. Biochem. Pharmacol.22, 311–322 (1973).
Vargaftig, B. B., Coignet, J. L., De Vos, C. J., Grijsen, H., Bonta, J. L.: Mianserin hydrochloride: peripheral and central effects in relation to antagonism against 5-hydroxytryptamine and tryptamine. Eur. J. Pharmacol.16, 336–346 (1971).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maj, J., Palider, W. & Baran, L. The effects of serotonergic and antiserotonergic drugs on the flexor reflex of spinal rat: a proposed model to evaluate the action on the central serotonin receptor. J. Neural Transmission 38, 131–147 (1976). https://doi.org/10.1007/BF01262971
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01262971